Clinical trial
Comparaison de Mesure de débit Cardiaque Entre système Clearsight® et Thermodilution Transpulmonaire.
NCT02728791 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparaison de Mesure de débit Cardiaque Entre système Clearsight® et Thermodilution Transpulmonaire.
- Lead sponsor
- University Hospital, Brest
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 10, 2016
- Completion date
- July 25, 2018
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.